Abstract
Regulatory and Clinical Expert Perspective of the 2022 FDA Draft Guidance “Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet”
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have